Coram (CRH)--has the turnaround begun Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Coram (CRH)--has the turnaround begun

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Tony van Werkhooven who wrote (19)	5/11/1998 4:33:00 PM
From: Lou Little	Read Replies (1) of 85

Is there money to be made in this industry? That is a very good question! Back in the 80's and early 90's, it was really hard NOT to make money in infusion therapy. Then managed care penetration, much lower pricing and tighter Medicare/Medicaid eligibility criteria took a huge chunk out of the potential revenue per patient. I mean a BIG chunk. Ever since 1994 or so, the industry has been consolidating in an attempt to survive as an industry (i.e., not part of some larger, more vertically integrated health system). AHG has indicated that some of their recent hard times are due to the deterioration of their infusion business (actually a small part of their total, predominantly Home Medical Equipment, base of business). Lincare does relatively little infusion therapy either (not a relevant comparison to Coram). Coram may survive, but it probably would be as a much smaller player. IMHO

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next